Stakeholders convene to draft state guidelines for medical AI oversight
A confidential workgroup of doctors, hospitals, insurers, AI firms and state officials met in Washington, D.C. to create draft rules for AI tools used in patient care.
In early October, a closed-door meeting in Washington, D.C. brought together representatives from major medical and technology sectors to shape how states regulate artificial intelligence in healthcare. The Federation of State Medical Boards convened a 22-member workgroup that features executives from the American Medical Association, American Hospital Association, AI developer Anthropic and insurer Elevance Health, alongside state officials.
According to FSMB president and CEO Humayun Chaudhry, the panel’s purpose is to balance expertise across medical regulation, AI development, care delivery, academic medicine, state AI policy and patient safety. The group will draft guidelines targeting AI tools that perform clinical functions with limited or no direct physician oversight. Draft recommendations are expected within weeks to months, will be opened for public feedback, and may later serve as the foundation for state legislation governing medical licensure and practice.
Why it matters
State medical boards could soon rely on these guidelines to regulate AI-driven clinical tools, affecting patient safety and healthcare delivery.
In this story
